The overexpression of cyclin D1 in cancer is mediated by CREPT interaction with the C-terminal domain (CTD) of RNAPII, which modulates the phosphorylation status of the CTD and translocates with RNAP II from promoter regions to 3′-untranslated regions (3′UTR) during in vivo transcription. Here, RPRD1B is linked to cancer.